Nurix Therapeutics, Inc. (NASDAQ:NRIX), a biopharmaceutical company specializing in protein degradation therapies, has been ...

In a recent industry report focused on Biotechnology stocks, particularly those innovating in neurology and psychiatry, ...

Israeli generics giant Teva Pharmaceutical Industries today reported results for the year and the quarter ended December 31, ...

Robert F. Kennedy Jr. may soon be America's top pharmaceutical regulator. That is cause for concern in Seattle’s biotech ...

Danaher on Wednesday missed Wall Street estimates for fourth-quarter profit due to soft demand for tools and services used in drug development by its biotech and pharmaceutical clients.

Despite continued underperformance in 2024, the biotech sector enters 2025 with a brighter outlook driven by groundbreaking ...

Alexandria Real Estate Equities (ARE) is the nation’s largest life sciences landlord with some of the world’s largest biotech ...

CRANBURY, NEW JERSEY / ACCESS Newswire / January 28, 2025 / AcceleDev Chemical LLC, a leading contract development and manufacturing organization (CDMO) specializing in custom synthesis and process de ...

An upstart biopharma firm founded by two former executives at CinCor Pharma – which celebrated a $1.8B exit to AstraZeneca in ...

Last year was a surprisingly big one for legal decisions impacting the biotechnology transactions and licensing space. Given that most biotech ...

A surge in biotech startup out-licensing deals from the country are paving the way for increased IPO and M&A activities.